205 related articles for article (PubMed ID: 37040756)
21. An autopsy case of progressive supranuclear palsy. Pallido-nigro-luysian type with argyrophilic grains clinically presenting with personality and behavioral changes.
Suzuki Y; Adachi T; Sakuwa M; Sakata R; Takigawa H; Hasegawa M; Hanajima R
Neuropathology; 2022 Oct; 42(5):447-452. PubMed ID: 35811445
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism.
Williams DR; de Silva R; Paviour DC; Pittman A; Watt HC; Kilford L; Holton JL; Revesz T; Lees AJ
Brain; 2005 Jun; 128(Pt 6):1247-58. PubMed ID: 15788542
[TBL] [Abstract][Full Text] [Related]
23. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
Jellinger KA
Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
[TBL] [Abstract][Full Text] [Related]
24. Tau-PET and multimodal imaging in clinically atypical multiple system atrophy masquerading as progressive supranuclear palsy.
Carlos AF; Sekiya H; Koga S; Pham NTT; Ali F; Botha H; Clark HM; Coon EA; Lowe V; Ahlskog JE; Trejo-Lopez JA; Dickson DW; Whitwell JL; Josephs KA
Parkinsonism Relat Disord; 2022 Aug; 101():9-14. PubMed ID: 35752126
[TBL] [Abstract][Full Text] [Related]
25. Age-, and gender-specific incidence of vascular parkinsonism, progressive supranuclear palsy, and parkinsonian-type multiple system atrophy in North East Scotland: the PINE study.
Caslake R; Taylor K; Scott N; Harris C; Gordon J; Wilde K; Murray A; Counsell C
Parkinsonism Relat Disord; 2014 Aug; 20(8):834-9. PubMed ID: 24814713
[TBL] [Abstract][Full Text] [Related]
26. Association of MAPT Subhaplotypes With Risk of Progressive Supranuclear Palsy and Severity of Tau Pathology.
Heckman MG; Brennan RR; Labbé C; Soto AI; Koga S; DeTure MA; Murray ME; Petersen RC; Boeve BF; van Gerpen JA; Uitti RJ; Wszolek ZK; Rademakers R; Dickson DW; Ross OA
JAMA Neurol; 2019 Jun; 76(6):710-717. PubMed ID: 30882841
[TBL] [Abstract][Full Text] [Related]
27. A clinicopathological study of vascular progressive supranuclear palsy: a multi-infarct disorder presenting as progressive supranuclear palsy.
Josephs KA; Ishizawa T; Tsuboi Y; Cookson N; Dickson DW
Arch Neurol; 2002 Oct; 59(10):1597-601. PubMed ID: 12374498
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank.
Josephs KA; Dickson DW
Mov Disord; 2003 Sep; 18(9):1018-26. PubMed ID: 14502669
[TBL] [Abstract][Full Text] [Related]
29. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
Lannuzel A; Höglinger GU; Verhaeghe S; Gire L; Belson S; Escobar-Khondiker M; Poullain P; Oertel WH; Hirsch EC; Dubois B; Ruberg M
Brain; 2007 Mar; 130(Pt 3):816-27. PubMed ID: 17303592
[TBL] [Abstract][Full Text] [Related]
30. Clinical heterogeneity in progressive supranuclear palsy: problems of clinical diagnostic criteria of NINDS-SPSP in a retrospective study of seven Japanese autopsy cases.
Sakamoto R; Tsuchiya K; Mimura M
Neuropathology; 2010 Feb; 30(1):24-35. PubMed ID: 19508347
[TBL] [Abstract][Full Text] [Related]
31. Cerebellar ataxia in progressive supranuclear palsy: An autopsy study of PSP-C.
Koga S; Josephs KA; Ogaki K; Labbé C; Uitti RJ; Graff-Radford N; van Gerpen JA; Cheshire WP; Aoki N; Rademakers R; Wszolek ZK; Ross OA; Dickson DW
Mov Disord; 2016 May; 31(5):653-62. PubMed ID: 26841329
[TBL] [Abstract][Full Text] [Related]
32. An autopsy-confirmed case of progressive supranuclear palsy with predominant postural instability.
Kurz C; Ebersbach G; Respondek G; Giese A; Arzberger T; Höglinger GU
Acta Neuropathol Commun; 2016 Nov; 4(1):120. PubMed ID: 27842578
[TBL] [Abstract][Full Text] [Related]
33. The diagnosis of progressive supranuclear palsy: current opinions and challenges.
Ali F; Josephs K
Expert Rev Neurother; 2018 Jul; 18(7):603-616. PubMed ID: 29902389
[TBL] [Abstract][Full Text] [Related]
34. Neuropathological findings of PSP in the elderly without clinical PSP: possible incidental PSP?
Evidente VG; Adler CH; Sabbagh MN; Connor DJ; Hentz JG; Caviness JN; Sue LI; Beach TG
Parkinsonism Relat Disord; 2011 Jun; 17(5):365-71. PubMed ID: 21420891
[TBL] [Abstract][Full Text] [Related]
35. Gradient subthalamic neurodegeneration and tau pathology in the hypoglossal nucleus as essential pathological markers of progressive supranuclear palsy - Richardson syndrome.
Homma T; Mochizuki Y; Hara M; Kamei S; Mizutani T; Takubo H; Isozaki E; Takahashi M; Komori T; Hao H
Rev Neurol (Paris); 2020 May; 176(5):353-360. PubMed ID: 32247606
[TBL] [Abstract][Full Text] [Related]
36. Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy.
Strickland SL; Morel H; Prusinski C; Allen M; Patel TA; Carrasquillo MM; Conway OJ; Lincoln SJ; Reddy JS; Nguyen T; Malphrus KG; Soto AI; Walton RL; Crook JE; Murray ME; Boeve BF; Petersen RC; Lucas JA; Ferman TJ; Uitti RJ; Wszolek ZK; Ross OA; Graff-Radford NR; Dickson DW; Ertekin-Taner N
Acta Neuropathol Commun; 2020 Oct; 8(1):172. PubMed ID: 33092647
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic accuracy of parkinsonism syndromes by general neurologists.
Joutsa J; Gardberg M; Röyttä M; Kaasinen V
Parkinsonism Relat Disord; 2014 Aug; 20(8):840-4. PubMed ID: 24816002
[TBL] [Abstract][Full Text] [Related]
38. Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia.
Hassan A; Parisi JE; Josephs KA
Neurocase; 2012; 18(6):478-88. PubMed ID: 22181323
[TBL] [Abstract][Full Text] [Related]
39. [Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis].
Morimatsu M; Negoro K; Mori H
Rinsho Shinkeigaku; 2004 Nov; 44(11):982-5. PubMed ID: 15651349
[TBL] [Abstract][Full Text] [Related]
40. Magnetic Resonance Parkinsonism Index for evaluating disease progression rate in progressive supranuclear palsy: A longitudinal 2-year study.
Quattrone A; Morelli M; Quattrone A; Vescio B; Nigro S; Arabia G; Nisticò R; Novellino F; Salsone M; Arcuri P; Luca A; Mazzuca A; Alessio C; Rocca F; Caracciolo M
Parkinsonism Relat Disord; 2020 Mar; 72():1-6. PubMed ID: 32036297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
